Conclusions About Milk Thistle (Chronic Hepatitis C)

Conclusions About Milk Thistle
A May 2005 review of clinical studies which casts doubt on milk thistle's value has recently been re-released into the press. Alternatively, an extensive amount of research supports the continued usage of this herb at higher dosages. Researchers of the...

Pegasys Shown More Effective In Study
Schering and Roche are taking part in dueling press releases. Each claiming their solution is better. Either way, they seem to be splitting hairs regarding effectiveness. There is no clear winner when they keep firing PR salvos back and forth....

Weight-based Treatment of HCV
Weight-based dosing has always made sense to us. We don't really understand why Roche has not changed their dosing to weight-based. Although the difference is subtle, it is certainly significant according to this study. You must also note, though, that...

Nurses and Hepatitis C (Chronic Hepatitis C)

Nurses and Hepatitis C
Officers Coinfection HIV & Viral Heaptitis: a guide December 2003 Third Edition Produced in Association with the Australian Liver Association, Gastroenterological Society of Australia

World J Gastroenterol
Lamivudine does not increase the efficacy of interferon in the treatment of mutant type chronic viral heaptitis B. Yang SS, Hsu CT, Hu JT, Lai YC, Wu CH

VIRAL HEPATITIS :: kerb.lambsw.com :: Viral Hepatitis
viral heaptitis ,

Pill Form of Therapy for HCV Coming Closer (Chronic Hepatitis C)

Pill Form of Therapy for HCV Coming Closer
This report is an update of therapy progress presented at the AASLD (American Academy for the Study of Liver Diseases). Three separate approaches are covered. Yes, progress is being made....

Ultrasound
Title: UltrasoundCategory: Procedures and TestsCreated: 12/31/1997Last Editorial Review: 10/15/2005

Viral Hepatitis
Title: Viral HepatitisCategory: Diseases and ConditionsCreated: 12/31/1997Last Editorial Review: 12/5/2005

Chronic Hepatitis C (Chronic Hepatitis C)

Chronic Hepatitis C
... Chronic Hepatitis C. The hepatitis C virus (HCV) is one of the most important causes of chronic liver disease in ... Chronic hepatitis C varies greatly in its course and outcome ...

Clinical Trial: Evaluating Silymarin for Chronic Hepatitis C
Evaluating Silymarin for Chronic Hepatitis C. This study is no longer recruiting patients. Information provided by: National Center for Complementary and Alternative Medicine (NCCAM) ClinicalTrials.gov Identifier: NCT00030030. Purpose

Hepatitis C
... Chronic Hepatitis C. Hepatitis C is a cause for concern for two reasons ... that about 20% of the patients with chronic hepatitis C will develop cirrhosis, and a few of ...

HepNet: Hepatitis C: TREATING YOUR CHRONIC HEPATITIS B OR C
Treatment for Hepatitis B and C ... As a result, your body more often needs help beating chronic hepatitis C ... Treatment often lasts much longer for chronic hepatitis C than for chronic hepatitis B; it may take ...

euro adhoc: Intercell AG / other / Intercell's Hepatitis C vaccine meets success criteria for further development - (Chronic Hepatitis C)

euro adhoc: Intercell AG / other / Intercell's Hepatitis C vaccine meets success criteria for further development -
Presseportal - Jan 31 8:59 AM
31.01.2006 Intercell (VSE; "ICLL") today announced initial data from a clinical trial aiming at the optimization of its therapeutic Hepatitis C vaccine IC41. Results ...Save to My Web

Hepatitis C recurs rapidly after liver transplant
EurekAlert! - Feb 02 6:56 AM
When a diseased liver is removed from a patient with Hepatitis C (HCV), serum viral levels plummet.Save to My Web

XTL Biopharmaceuticals to Present at the JPMorgan Small Cap Conference
[Press Release] PR Newswire via Yahoo! Finance - Feb 13 12:05 AM
XTL Biopharmaceuticals, Ltd. , a biopharmaceutical company developing drugs against hepatitis, announced today that Ron Bentsur, Chief Executive Officer, will present an overview of the Company at The JPMorgan Small Cap Conference in Philadelphia.Save to My Web

(AFX UK Focus) 2006-02-09 17:07 GMT: UK small caps end higher, Network Tech rallies, Hawtin up on stake build
Interactive Investor - Feb 09 9:35 AM
LONDON (AFX) - UK small caps end the session higher with Network Technology surging over 34 pct on news that it expects to reap the benefits of the tax relief in the second quarter of this year, while Hawtin's shares rally on news Gracelands Investments has increased its stake, dealers said.Save to My Web

BioCryst to Present at the BIO CEO & Investor Conference 2006
FinanzNachrichten - Feb 10 4:40 AM
BioCryst Pharmaceuticals, Inc. designs, optimizes and develops novel drugs that block key enzymes involved in cancer, cardiovascular diseases, autoimmune diseases, and viral infections.Save to My Web

HCV readymade alignments (Chronic Hepatitis C)

HCV readymade alignments
HCV sequence database. HCV readymade alignments. Help the effort to obtain more complete genome sequences by donating samples! ...

Hepatitis C: Index | CDC Viral Hepatitis
HIV/HCV Co-infection Center of Excellence: a national resource on HIV/HCV co-infection for clinicians and health professionals. StopHep. ...

National HCV Prison Coalition - Hepatitis C Awareness Project
The National Hepatitis C Prison Coalition provides support to prison inmates who are suffering from hepatitis C (HCV) and HIV/HCV coinfection.

HCV Forum with Dr. Ben Cecil
Welcome to the HCV forum. I have been interested in treating patients with HCV for five years and have treated more than 1800 patients with antiviral ...